Login Register Cart 0
Generic placeholder image

Current Molecular Medicine

Editor-in-Chief

ISSN (Print): 1566-5240
ISSN (Online): 1875-5666

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
Research Article

Anti-Cancer and Anti-Oxidant Effects of Fenoferin-loaded Human Serum Albumin Nanoparticles Coated with Folic Acid-bound Chitosan

Author(s): Methaq Abid Said Klmohamed Almusawi, Vahid Pouresmaeil* and Masoud Homayouni Tabrizi

Volume 25, Issue 5, 2025

Published on: 19 February, 2024

Page: [614 - 625] Pages: 12

DOI: 10.2174/0115665240283529240202095254

Price: $65

Abstract

Background: Several diseases, including cancer, can be effectively treated by altering the nanocarrier surfaces so that they are more likely to be targeted.

Objective: This study aimed to prepare human albumin (HSA) nanoparticles containing Fenoferin (FN) modified with folic acid (FA) attached to Chitosan (CS) to improve its anti-cancer properties.

Methods: Nanoparticles were first synthesized and surface modified. Their physicochemical properties were assessed by different methods, such as FESEM, FTIR, and DLS. In addition, the percentage of drug encapsulated was measured by indirect method. Besides evaluating the cytotoxic effects of nanoparticles using the MTT assay, the antioxidant capacity of FN-HSA-CS-FA was assessed using the ABTS and DPPH methods. Nanoparticles were also investigated for their anti-cancer effects by evaluating the expression of apoptosis and metastasis genes.

Results: Based on this study, FN-HSA-CS-FA was 165.46 nm in size, and a uniform dispersion distribution was identified. Particles were reported to have a zeta potential of +29 mV, which is within the range of stable nanoparticles. Approximately 75% of FN is encapsulated in nanoparticles. Cytotoxic assay determined that liver cancer cells were most sensitive to treatment with an IC50 of 144 μg/ml. Inhibition of free radicals by nanoparticles is estimated to have an IC50 value of 195.23 and 964 μg/ml, for ABTS and DPPH, respectively. In the treatment with nanoparticles, flow cytometry results of arresting the cells in the SubG1 phase and real-time qPCR results indicated increased expression of caspases-3, caspase-8, and caspase-9 genes.

Conclusion: According to this study, synthesized nanoparticles inhibited free radicals and activated apoptosis in liver cancer cells, and the capability of these nanoparticles to inhibit cancer cells was also confirmed. This formulation can, therefore, be used in preclinical studies to test the efficacy of the drug.

Keywords: Fenoferin, human serum albumin, chitosan, folic acid, active targeting, cancer.

« Previous Next »
[1]
Saini A, Kumar M, Bhatt S, Saini V, Malik A. Cancer causes and treatments. Int J Pharm Sci Res 2020; 11(7): 3121-34.
[2]
Kifle ZD, Tadele M, Alemu E, Gedamu T, Ayele AG. A recent development of new therapeutic agents and novel drug targets for cancer treatment. SAGE Open Med 2021; 9.
[http://dx.doi.org/10.1177/20503121211067083] [PMID: 34992782]
[3]
Ulldemolins A, Seras-Franzoso J, Andrade F, et al. Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics. Cancer Drug Resist 2021; 4(1): 44-68.
[http://dx.doi.org/10.20517/cdr.2020.59] [PMID: 35582007]
[4]
Martínez-Relimpio AM, Benito M, Pérez-Izquierdo E, Teijón C, Olmo RM, Blanco MD. Paclitaxel-loaded folate-targeted albumin-alginate nanoparticles crosslinked with ethylenediamine. synthesis and in vitro characterization. Polymers 2021; 13(13): 2083.
[http://dx.doi.org/10.3390/polym13132083] [PMID: 34202848]
[5]
Mashreghi M, Faal Maleki M, Karimi M, Kalalinia F, Badiee A, Jaafari MR. Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide. J Drug Target 2021; 29(6): 617-30.
[http://dx.doi.org/10.1080/1061186X.2020.1870230] [PMID: 33393376]
[6]
Jeong K, Kang CS, Kim Y, Lee YD, Kwon IC, Kim S. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy. Cancer Lett 2016; 374(1): 31-43.
[http://dx.doi.org/10.1016/j.canlet.2016.01.050] [PMID: 26854717]
[7]
Pandey H, Rani R, Agarwal V. Liposome and their applications in cancer therapy. Braz Arch Biol Technol 2016; 59(0): 59.
[http://dx.doi.org/10.1590/1678-4324-2016150477]
[8]
Arora V, Abourehab MAS, Modi G, Kesharwani P. Dendrimers as prospective nanocarrier for targeted delivery against lung cancer. Eur Polym J 2022; 180: 111635.
[http://dx.doi.org/10.1016/j.eurpolymj.2022.111635]
[9]
Rezvantalab S, Drude NI, Moraveji MK, et al. PLGA-based nanoparticles in cancer treatment. Front Pharmacol 2018; 9: 1260.
[http://dx.doi.org/10.3389/fphar.2018.01260] [PMID: 30450050]
[10]
Kratz F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008; 132(3): 171-83.
[http://dx.doi.org/10.1016/j.jconrel.2008.05.010] [PMID: 18582981]
[11]
Lomis N, Westfall S, Farahdel L, Malhotra M, Shum-Tim D, Prakash S. Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization. Nanomaterials 2016; 6(6): 116.
[http://dx.doi.org/10.3390/nano6060116] [PMID: 28335244]
[12]
Rabea EI, Badawy MET, Stevens CV, Smagghe G, Steurbaut W. Chitosan as antimicrobial agent: Applications and mode of action. Biomacromolecules 2003; 4(6): 1457-65.
[http://dx.doi.org/10.1021/bm034130m] [PMID: 14606868]
[13]
Hamedinasab H, Rezayan AH, Mellat M, Mashreghi M, Jaafari MR. Development of chitosan-coated liposome for pulmonary delivery of N-acetylcysteine. Int J Biol Macromol 2020; 156: 1455-63.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.11.190] [PMID: 31770553]
[14]
Jain KK. Role of nanobiotechnology in drug delivery. Methods Mol Biol 2020; 2059: 55-73.
[http://dx.doi.org/10.1007/978-1-4939-9798-5_2] [PMID: 31435915]
[15]
Sadi KS, Mahmoudi A, Jaafari MR, Moosavian SA, Malaekeh-Nikouei B. The effect of AS1411 aptamer on anti-tumor effects of dendrimers containing SN38. J Drug Deliv Sci Technol 2022; 75: 103624.
[http://dx.doi.org/10.1016/j.jddst.2022.103624]
[16]
Yazdian-Robati R, Amiri E, Kamali H, et al. CD44-specific short peptide A6 boosts cellular uptake and anticancer efficacy of PEGylated liposomal doxorubicin in vitro and in vivo. Cancer Nanotechnol 2023; 14(1): 84.
[http://dx.doi.org/10.1186/s12645-023-00236-0]
[17]
Sarhadi S, Moosavian SA, Mashreghi M, et al. B12-functionalized PEGylated liposomes for the oral delivery of insulin: in vitro and in vivo studies. J Drug Deliv Sci Technol 2022; 69: 103141.
[http://dx.doi.org/10.1016/j.jddst.2022.103141]
[18]
Tagde P, Kulkarni GT, Mishra DK, Kesharwani P. Recent advances in folic acid engineered nanocarriers for treatment of breast cancer. J Drug Deliv Sci Technol 2020; 56: 101613.
[http://dx.doi.org/10.1016/j.jddst.2020.101613]
[19]
Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008; 41(1): 120-9.
[http://dx.doi.org/10.1021/ar7000815] [PMID: 17655275]
[20]
Song H, Su C, Cui W, Zhu B, Liu L, Chen Z, et al. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery. BioMed Res Int 2013; 2013: 723158.
[http://dx.doi.org/10.1155/2013/723158]
[21]
Jang EH, Shim MK, Kim GL, Kim S, Kang H, Kim JH. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment. Int J Pharm 2020; 580: 119237.
[http://dx.doi.org/10.1016/j.ijpharm.2020.119237] [PMID: 32201251]
[22]
Zare Mirakabad H, Khorramizadeh MR. Introduction to the potential of Ferula ovina in dental implant research due to estrogenic bioactive compounds and adhesive properties. PLoS One 2022; 17(1): e0262045.
[http://dx.doi.org/10.1371/journal.pone.0262045] [PMID: 35041680]
[23]
Mehravar R, Jahanshahi M, Saghatoleslami N. Fabrication and evaluation of human serum albumin (HSA) nanoparticles for drug delivery application. Int J Nanosci 2009; 8(3): 319-22.
[http://dx.doi.org/10.1142/S0219581X09006080]
[24]
Al-Salih MYA, Pouresmaeil V, Davoodi-Dehaghani F, Haghighi HN, Tabrizi MH. Study the anticancer properties of thymol-loaded PEGylated bovine serum albumin nanoparticles conjugated with folic acid. Chem Biodiv 2023; 20(11): e202301122.
[http://dx.doi.org/10.1002/cbdv.202301122]
[25]
Mashreghi M, Zamani P, Karimi M, et al. Anti‐ epithelial cell adhesion molecule RNA aptamer‐conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model. Biotechnol Prog 2021; 37(3): e3116.
[http://dx.doi.org/10.1002/btpr.3116] [PMID: 33369269]
[26]
Tang J, Lu X, Chen B, et al. Mechanisms of silver nanoparticles-induced cytotoxicity and apoptosis in rat tracheal epithelial cells. J Toxicol Sci 2019; 44(3): 155-65.
[http://dx.doi.org/10.2131/jts.44.155] [PMID: 30842368]
[27]
Khuda F, Jamil M, Ali Khan Khalil A, et al. Assessment of antioxidant and cytotoxic potential of silver nanoparticles synthesized from root extract of Reynoutria japonica Houtt. Arab J Chem 2022; 15(12): 104327.
[http://dx.doi.org/10.1016/j.arabjc.2022.104327]
[28]
Nosrati H, Abbasi R, Charmi J, et al. Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells. Int J Biol Macromol 2018; 117: 1125-32.
[http://dx.doi.org/10.1016/j.ijbiomac.2018.06.026] [PMID: 29885392]
[29]
Valdebenito A, Espinoza P, Lissi EA, Encinas MV. Bovine serum albumin as chain transfer agent in the acrylamide polymerization. Protein-polymer conjugates. Polymer 2010; 51(12): 2503-7.
[http://dx.doi.org/10.1016/j.polymer.2010.04.015]
[30]
Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy. J Nanobiotechnol 2012; 10(1): 38.
[http://dx.doi.org/10.1186/1477-3155-10-38] [PMID: 22937885]
[31]
Souza TG, Ciminelli VS, Mohallem NDS. Eds. A comparison of TEM and DLS methods to characterize size distribution of ceramic nanoparticles. J Phys: Conf Series 2016.
[32]
Neofytou P, Theodosiou M, Krokidis MG, Efthimiadou EK. Simulation of colloidal stability and aggregation tendency of magnetic nanoflowers in biofluids. Modelling 2021; 3(1): 14-26.
[http://dx.doi.org/10.3390/modelling3010002]
[33]
Wang Y, Li P, Kong L. Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery. AAPS PharmSciTech 2013; 14(2): 585-92.
[http://dx.doi.org/10.1208/s12249-013-9943-3] [PMID: 23463262]
[34]
Piazzini V, Landucci E, D’Ambrosio M, et al. Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery. Int J Biol Macromol 2019; 129: 267-80.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.02.005] [PMID: 30726749]
[35]
Shi P, Cheng Z, Zhao K, et al. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. J Nanobiotechnol 2023; 21(1): 103.
[http://dx.doi.org/10.1186/s12951-023-01826-1] [PMID: 36944946]
[36]
Salahpour Anarjan F. Active targeting drug delivery nanocarriers: Ligands. Nano-Struct Nano-Objects 2019; 19: 100370.
[http://dx.doi.org/10.1016/j.nanoso.2019.100370]
[37]
Yoo J, Park C, Yi G, Lee D, Koo H. Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers 2019; 11(5): 640.
[http://dx.doi.org/10.3390/cancers11050640] [PMID: 31072061]
[38]
Zwicke GL, Ali Mansoori G, Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev 2012; 3(1): 18496.
[http://dx.doi.org/10.3402/nano.v3i0.18496] [PMID: 23240070]
[39]
Fernández M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment/imaging of cancers. Chem Sci 2018; 9(4): 790-810.
[http://dx.doi.org/10.1039/C7SC04004K] [PMID: 29675145]
[40]
Pirali-Hamedani Z, Abbasi A, Hassan ZM. Synthesis of artemether-loaded albumin nanoparticles and measurement of their anti-cancer effects. Biomedicines 2022; 10(11): 2713.
[http://dx.doi.org/10.3390/biomedicines10112713] [PMID: 36359230]
[41]
Lustriane C, Dwivany FM, Suendo V, Reza M. Effect of chitosan and chitosan-nanoparticles on post harvest quality of banana fruits. J Plant Biotechnol 2018; 45(1): 36-44.
[http://dx.doi.org/10.5010/JPB.2018.45.1.036]
[42]
Zhang X, Zhang L, Zheng D, et al. A natural monoterpene enol for dispersive liquid–liquid microextraction based on solidification of floating organic droplets for determination of benzophenone compounds in water samples. Separations 2022; 10(1): 1.
[http://dx.doi.org/10.3390/separations10010001]
[43]
Marshalek JP, Sheeran PS, Ingram P, Dayton PA, Witte RS, Matsunaga TO. Intracellular delivery and ultrasonic activation of folate receptor-targeted phase-change contrast agents in breast cancer cells in vitro J Control Release 2016; 243: 69-77.
[http://dx.doi.org/10.1016/j.jconrel.2016.09.010] [PMID: 27686582]
[44]
Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnol 2018; 16(1): 71.
[http://dx.doi.org/10.1186/s12951-018-0392-8] [PMID: 30231877]
[45]
Maroufi NF, Vahedian V, Mazrakhondi SAM, et al. Sensitization of MDA-MBA231 breast cancer cell to docetaxel by myricetin loaded into biocompatible lipid nanoparticles via sub-G1 cell cycle arrest mechanism. Naunyn Schmiedebergs Arch Pharmacol 2020; 393(1): 1-11.
[http://dx.doi.org/10.1007/s00210-019-01692-5] [PMID: 31372697]
[46]
Liu F, Lan M, Ren B, et al. Baicalin-loaded folic acid-modified albumin nanoparticles (FA-BSANPs/BA) induce autophagy in MCF-7 cells via ROS-mediated p38 MAPK and Akt/mTOR pathway. Cancer Nanotechnol 2022; 13(1): 2.
[http://dx.doi.org/10.1186/s12645-021-00110-x]
[47]
Kruidering M, Evan GI. Caspase-8 in apoptosis: The beginning of “the end”? IUBMB Life 2000; 50(2): 85-90.
[PMID: 11185963]
[48]
Aral K, Aral CA, Kapila Y. The role of caspase‐8, caspase‐9, and apoptosis inducing factor in periodontal disease. J Periodontol 2019; 90(3): 288-94.
[http://dx.doi.org/10.1002/JPER.17-0716] [PMID: 30311940]
[49]
Brentnall M, Rodriguez-Menocal L, De Guevara RL, Cepero E, Boise LH. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol 2013; 14(1): 32.
[http://dx.doi.org/10.1186/1471-2121-14-32] [PMID: 23834359]
[50]
Rahimi Z, Yari K, Rahimi Z. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer. Asian Pac J Cancer Prev 2015; 16(3): 1175-9.
[http://dx.doi.org/10.7314/APJCP.2015.16.3.1175] [PMID: 25735351]
[51]
Ganguly K, Maity P, Reiter RJ, Swarnakar S. Effect of melatonin on secreted and induced matrix metalloproteinase‐9 and ‐2 activity during prevention of indomethacin‐induced gastric ulcer. J Pineal Res 2005; 39(3): 307-15.
[http://dx.doi.org/10.1111/j.1600-079X.2005.00250.x] [PMID: 16150113]
[52]
Soltani M, Etminan A, Rahmati A, Behjati Moghadam M, Ghaderi Segonbad G, Homayouni Tabrizi M. Incorporation of Boswellia sacra essential oil into chitosan/TPP nanoparticles towards improved therapeutic efficiency. Mater Technol 2021; 1-13.

Rights & Permissions Print Cite
Article Metrics
28
2
Wayfinder Image
© 2025 Bentham Science Publishers | Privacy Policy